217326-65-3 Usage
General Description
4-Bromobenzo[d]oxazole is a chemical compound that belongs to the class of organic compounds known as benzo[d]oxazoles, which are aromatic heterocyclic compounds containing a benzene fused to an oxazole ring. It has the molecular formula C7H4BrNO. 4-Bromobenzo[d]oxazole is a widely used chemical reagent frequently utilized as an intermediate in the preparation of more complex organic substances. Its bromine atom makes it an excellent candidate for cross-coupling reactions, often used in pharmaceutical synthesis or material science. As with all chemicals, it should be handled with care as its effects on human health and the environment have not been exhaustively studied.
Check Digit Verification of cas no
The CAS Registry Mumber 217326-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,7,3,2 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 217326-65:
(8*2)+(7*1)+(6*7)+(5*3)+(4*2)+(3*6)+(2*6)+(1*5)=123
123 % 10 = 3
So 217326-65-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrNO/c8-5-2-1-3-6-7(5)9-4-10-6/h1-4H
217326-65-3Relevant articles and documents
METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS
-
Paragraph 0306, (2020/01/24)
Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.
IMIDAZO [1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
-
Paragraph 00545, (2017/11/04)
The invention provides substituted imidazo[1,5-a]pyrimidinyl carboxamide and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,5-a]pyrimidinyl carboxamide compounds described herein include substituted 2-heterocyclyl-4-alkyl-imidazo[1,5-a]pyrirnidine-8-carboxamide compounds and variants thereof.
